These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 30802452

  • 1. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1<alpha> signaling pathway.
    Liu P, Gu Y, Luo J, Ye P, Zheng Y, Yu W, Chen S.
    Exp Cell Res; 2019 Jul 01; 380(1):36-46. PubMed ID: 30802452
    [Abstract] [Full Text] [Related]

  • 2. Role of Src tyrosine kinases in experimental pulmonary hypertension.
    Pullamsetti SS, Berghausen EM, Dabral S, Tretyn A, Butrous E, Savai R, Butrous G, Dahal BK, Brandes RP, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Rosenkranz S, Schermuly RT.
    Arterioscler Thromb Vasc Biol; 2012 Jun 01; 32(6):1354-65. PubMed ID: 22516066
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y, Yin L, Zhu M, Song S, Sun C, Han X, Xu Y, Zhao Y, Qi Y, Xu L, Peng JY.
    Biomed Pharmacother; 2021 Jan 01; 133():111056. PubMed ID: 33378960
    [Abstract] [Full Text] [Related]

  • 4. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
    Chen M, Shen H, Zhu L, Yang H, Ye P, Liu P, Gu Y, Chen S.
    J Cell Physiol; 2019 Aug 01; 234(10):17482-17493. PubMed ID: 30786011
    [Abstract] [Full Text] [Related]

  • 5. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Xiao Y, Peng H, Hong C, Chen Z, Deng X, Wang A, Yang F, Yang L, Chen C, Qin X.
    Cell Physiol Biochem; 2017 Aug 01; 42(4):1603-1613. PubMed ID: 28738389
    [Abstract] [Full Text] [Related]

  • 6. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S, Peng F, Li ML, Duan WB, Peng CQ, Wu SJ.
    Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H377-H391. PubMed ID: 32559140
    [Abstract] [Full Text] [Related]

  • 7. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
    Xu Y, Sun Z, Wang Q, Wang T, Liu Y, Yu F.
    Vascul Pharmacol; 2019 Sep 01; 120():106568. PubMed ID: 31207359
    [Abstract] [Full Text] [Related]

  • 8. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    Luo S, Kan J, Zhang J, Ye P, Wang D, Jiang X, Li M, Zhu L, Gu Y.
    J Cardiovasc Pharmacol; 2021 Aug 01; 78(2):253-262. PubMed ID: 34554677
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of Angiomotin-Like 2 Ameliorates Experimental Pulmonary Arterial Hypertension by Inactivating YAP1 Signaling.
    Deng J, Yang G, Zhong N, Liang L, Chen H.
    J Cardiovasc Pharmacol; 2024 Sep 01; 84(3):356-369. PubMed ID: 39027975
    [Abstract] [Full Text] [Related]

  • 10. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue H, Yuan T, Yang P, Xiong F, Zhang S, Zhou Q, Chen Z, Li J, Mo BW, Zhang H, Xiong W, Wang CY.
    Cell Prolif; 2020 Feb 01; 53(2):e12742. PubMed ID: 31943454
    [Abstract] [Full Text] [Related]

  • 11. Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro.
    Luo J, Gu Y, Liu P, Jiang X, Yu W, Ye P, Chao Y, Yang H, Zhu L, Zhou L, Chen S.
    J Cell Physiol; 2018 Dec 01; 233(12):9750-9762. PubMed ID: 30078229
    [Abstract] [Full Text] [Related]

  • 12. Chlorogenic acid inhibits hypoxia-induced pulmonary artery smooth muscle cells proliferation via c-Src and Shc/Grb2/ERK2 signaling pathway.
    Li QY, Zhu YF, Zhang M, Chen L, Zhang Z, Du YL, Ren GQ, Tang JM, Zhong MK, Shi XJ.
    Eur J Pharmacol; 2015 Mar 15; 751():81-8. PubMed ID: 25666384
    [Abstract] [Full Text] [Related]

  • 13. Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension.
    Yu X, Zhao X, Zhang J, Li Y, Sheng P, Ma C, Zhang L, Hao X, Zheng X, Xing Y, Qiao H, Qu L, Zhu D.
    Eur J Pharmacol; 2019 May 05; 850():97-108. PubMed ID: 30753867
    [Abstract] [Full Text] [Related]

  • 14. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.
    Zhang L, Pu Z, Wang J, Zhang Z, Hu D, Wang J.
    Int J Mol Sci; 2014 May 09; 15(5):8153-68. PubMed ID: 24821539
    [Abstract] [Full Text] [Related]

  • 15. Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
    Cheng CC, Chi PL, Shen MC, Shu CW, Wann SR, Liu CP, Tseng CJ, Huang WC.
    Int J Mol Sci; 2019 Mar 22; 20(6):. PubMed ID: 30909527
    [Abstract] [Full Text] [Related]

  • 16. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
    He Y, Cao X, Liu X, Li X, Xu Y, Liu J, Shi J.
    Exp Cell Res; 2015 Nov 15; 339(1):122-34. PubMed ID: 26476374
    [Abstract] [Full Text] [Related]

  • 17. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Huang W, Zhou H, He Y, Wang A, Wang B, Chen Y, Liu C, Wang H, Xie W, Kong H.
    Exp Cell Res; 2024 Aug 01; 441(1):114154. PubMed ID: 38996959
    [Abstract] [Full Text] [Related]

  • 18. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ, Hsu HC, Ho WJ, Chang GJ, Pang JS, Chen WJ, Huang CC, Lai YJ.
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul 01; 317(1):L1-L13. PubMed ID: 31017016
    [Abstract] [Full Text] [Related]

  • 19. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y, Zuo C, Jia D, Bai P, Kong D, Chen D, Liu G, Li J, Wang Y, Chen G, Yan S, Xiao B, Zhang J, Piao L, Li Y, Deng Y, Li B, Roux PP, Andreasson KI, Breyer RM, Su Y, Wang J, Lyu A, Shen Y, Yu Y.
    Am J Respir Crit Care Med; 2020 May 15; 201(10):1263-1276. PubMed ID: 31917615
    [Abstract] [Full Text] [Related]

  • 20. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
    Marsboom G, Toth PT, Ryan JJ, Hong Z, Wu X, Fang YH, Thenappan T, Piao L, Zhang HJ, Pogoriler J, Chen Y, Morrow E, Weir EK, Rehman J, Archer SL.
    Circ Res; 2012 May 25; 110(11):1484-97. PubMed ID: 22511751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.